Clinical Trial Update: Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing febuxostat versus vitamin E for non-alcoholic steatohepatitis with hyperuricemia; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia
• Non-alcoholic Steatohepatitis

Drugs mentioned

• FEBUXOSTAT (Febuxostat)
• Vitamin E (tocopherol)

Snippet

Sponsor: Tanta University | Conditions: Non Alcoholic Steatohepatitis, Hyperuricemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING